Atrial Fibrillation Risk Assessment

The diagnosis of Atrial Fibrillation (AFib) requires careful risk stratification to determine the appropriate balance between preventing stroke and avoiding excessive bleeding. Simply calculating a score is not enough; clinicians need integrated guidance.

The Problem: Traditional assessment methods often evaluate thromboembolic risk and hemorrhagic risk separately, leading to disjointed treatment plans. A patient with high AFib risk but also high bleeding risk needs nuanced advice that weighs both factors simultaneously.

Our Mechanism (Tools): This MCP connector provides a three-step workflow using specialized tools:

1. query_cha2ds2_vasc_score: Calculates the total CHA₂DS₂-VASc score based on patient demographics and comorbidities (sex, age, HTN, DM, etc.).
2. calculate_hasbled_score: Assesses the bleeding risk using the HAS-BLED scale, considering factors like blood pressure control and diuretic use.
3. get_risk_recommendations: Takes both scores to generate a final recommendation, providing the annual stroke risk percentage (based on ESC 2020 criteria) and definitive anticoagulant guidance ('O' or 'A').

Advantage: By running these tools together, agents can provide comprehensive patient care pathways. Instead of just listing a score, they deliver actionable advice that synthesizes both high thromboembolic risk and high bleeding risk concerns, guiding the clinician toward optimal therapy.